Column Group II GP, LP

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ The Column Group II GP, LP /s/ James Evangelista, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Column Group II GP, LP

Form 4 holding 10%+ Owner

eFFECTOR Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,309,329
Estimated value
$2,613,608
Report date
25 Aug 2021
Price
$0.6065
Ownership
Indirect

Insider Reports Filed by Column Group II GP, LP

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .